Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KL4E
|
|||
| Drug Name |
SAR422459
|
|||
| Indication | Stargardt disease [ICD-11: 9B70; ICD-10: H35.5] | Phase 1/2 | [1] | |
| Company |
Sanofi US, Bridgewater, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01367444) Phase I/IIa Study of StarGen in Patients With Stargardt's Macular Degeneration. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.